145 related articles for article (PubMed ID: 26400062)
21. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
22. Autocrine PDGFR signaling promotes mammary cancer metastasis.
Jechlinger M; Sommer A; Moriggl R; Seither P; Kraut N; Capodiecci P; Donovan M; Cordon-Cardo C; Beug H; Grünert S
J Clin Invest; 2006 Jun; 116(6):1561-70. PubMed ID: 16741576
[TBL] [Abstract][Full Text] [Related]
23. Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy.
Abravanel DL; Belka GK; Pan TC; Pant DK; Collins MA; Sterner CJ; Chodosh LA
J Clin Invest; 2015 Jun; 125(6):2484-96. PubMed ID: 25961456
[TBL] [Abstract][Full Text] [Related]
24. [Survival of patients with metastatic breast cancer according to pathological types of tumors].
Sánchez R C; Acevedo C F; Petric G M; Galindo A H; Domínguez C F; León R A; Razmilic V D; Ceballos C; Espinoza F; Navarro O ME; Oddó B D; Camus A M
Rev Med Chil; 2014 Apr; 142(4):428-35. PubMed ID: 25117032
[TBL] [Abstract][Full Text] [Related]
25. GATA3 expression in advanced breast cancer: prognostic value and organ-specific relapse.
McCleskey BC; Penedo TL; Zhang K; Hameed O; Siegal GP; Wei S
Am J Clin Pathol; 2015 Nov; 144(5):756-63. PubMed ID: 26486740
[TBL] [Abstract][Full Text] [Related]
26. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
27. In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models.
Hoeflich KP; O'Brien C; Boyd Z; Cavet G; Guerrero S; Jung K; Januario T; Savage H; Punnoose E; Truong T; Zhou W; Berry L; Murray L; Amler L; Belvin M; Friedman LS; Lackner MR
Clin Cancer Res; 2009 Jul; 15(14):4649-64. PubMed ID: 19567590
[TBL] [Abstract][Full Text] [Related]
28. Different prognostic significance of Ki-67 change between pre- and post-neoadjuvant chemotherapy in various subtypes of breast cancer.
Matsubara N; Mukai H; Fujii S; Wada N
Breast Cancer Res Treat; 2013 Jan; 137(1):203-12. PubMed ID: 23184081
[TBL] [Abstract][Full Text] [Related]
29. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
30. Is biological subtype prognostic of locoregional recurrence risk in women with pT1-2N0 breast cancer treated with mastectomy?
Truong PT; Sadek BT; Lesperance MF; Alexander CS; Shenouda M; Raad RA; Taghian AG
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):57-64. PubMed ID: 24161421
[TBL] [Abstract][Full Text] [Related]
31. Coordinate hyperactivation of Notch1 and Ras/MAPK pathways correlates with poor patient survival: novel therapeutic strategy for aggressive breast cancers.
Mittal S; Sharma A; Balaji SA; Gowda MC; Dighe RR; Kumar RV; Rangarajan A
Mol Cancer Ther; 2014 Dec; 13(12):3198-3209. PubMed ID: 25253780
[TBL] [Abstract][Full Text] [Related]
32. S100A4 Elevation Empowers Expression of Metastasis Effector Molecules in Human Breast Cancer.
Ismail TM; Bennett D; Platt-Higgins AM; Al-Medhity M; Barraclough R; Rudland PS
Cancer Res; 2017 Feb; 77(3):780-789. PubMed ID: 27927689
[TBL] [Abstract][Full Text] [Related]
33. Effective personalized therapy for breast cancer based on predictions of cell signaling pathway activation from gene expression analysis.
Jhan JR; Andrechek ER
Oncogene; 2017 Jun; 36(25):3553-3561. PubMed ID: 28135251
[TBL] [Abstract][Full Text] [Related]
34. Luminal breast cancer metastasis is dependent on estrogen signaling.
Ganapathy V; Banach-Petrosky W; Xie W; Kareddula A; Nienhuis H; Miles G; Reiss M
Clin Exp Metastasis; 2012 Jun; 29(5):493-509. PubMed ID: 22427027
[TBL] [Abstract][Full Text] [Related]
35. Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers.
Olsen SN; Wronski A; Castaño Z; Dake B; Malone C; De Raedt T; Enos M; DeRose YS; Zhou W; Guerra S; Loda M; Welm A; Partridge AH; McAllister SS; Kuperwasser C; Cichowski K
Cancer Discov; 2017 Feb; 7(2):202-217. PubMed ID: 27974415
[TBL] [Abstract][Full Text] [Related]
36. Transforming Growth Factor-beta Regulation of Ephrin Type-A Receptor 4 Signaling in Breast Cancer Cellular Migration.
Hachim IY; Villatoro M; Canaff L; Hachim MY; Boudreault J; Haiub H; Ali S; Lebrun JJ
Sci Rep; 2017 Nov; 7(1):14976. PubMed ID: 29101386
[TBL] [Abstract][Full Text] [Related]
37. Igf1r as a therapeutic target in a mouse model of basal-like breast cancer.
Klinakis A; Szabolcs M; Chen G; Xuan S; Hibshoosh H; Efstratiadis A
Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2359-64. PubMed ID: 19174523
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical Staining for Ras-Related Protein 25 (RAB25) Associates with Luminal B Breast Cancer Subtype.
Belhadj A; Addou-Klouche L; Bouakline I; Medjamia M; Benammar HJ; Sahraoui T
Gulf J Oncolog; 2020 Jan; 1(32):26-33. PubMed ID: 32342915
[TBL] [Abstract][Full Text] [Related]
39. Mutant RAS-driven Secretome Causes Skeletal Muscle Defects in Breast Cancer.
Wang R; Khatpe AS; Kumar B; Mang HE; Batic K; Adebayo AK; Nakshatri H
Cancer Res Commun; 2024 May; 4(5):1282-1295. PubMed ID: 38651826
[TBL] [Abstract][Full Text] [Related]
40. Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors.
Pérez-Peña J; Alcaraz-Sanabria A; Nieto-Jiménez C; Páez R; Corrales-Sánchez V; Serrano-Oviedo L; Wali VB; Patwardhan GA; Amir E; Győrffy B; Pandiella A; Ocaña A
Oncotarget; 2017 Mar; 8(13):21733-21740. PubMed ID: 28423514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
